Laverock Therapeutics
Laverock Therapeutics

Laverock Therapeutics

Measured by AhrefsDR25Ahrefs DR: 25/100. Below median. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed75Site Speed: 75/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust81Data Trust: 81/100. Top 25%. Measured by StartupHub.ai. Median 61.

Developing disease-responsive advanced therapies through programmable gene control technology.

2020ActiveCambridge, United Kingdom

About

Laverock Therapeutics develops programmable advanced therapies that are disease-responsive, utilizing unique platform technologies for precise gene control. Their system enables therapies to act only where and when needed, with enhanced precision and improved safety profiles. They serve the biotechnology and pharmaceutical industries by transforming therapeutic and non-therapeutic applications through their modular technology platforms and advanced therapy pipeline.

Key facts

Website
laverocktx.com
Headquarters
Cambridge, England, United Kingdom
Founded
2020
Total funding
$10M (Seed)
Business model
B2B

Funding rounds

Funding rounds raised by Laverock Therapeutics
DateRoundAmountLead investors
26 Jan 2023Seed$10M

Tech stack

Detected on laverocktx.com, last scanned 22 Sept 2026.

Analytics
Google Tag Manager
CMS / Builders
Webflow
CDN
Cloudflare
Email provider
Microsoft 365

Laverock Therapeutics scores 25. Does yours?

That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.

Add first review

Frequently asked

Is Laverock Therapeutics trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Laverock Therapeutics is 81 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Laverock Therapeutics raised?

Laverock Therapeutics has raised a total of $10M in funding. The most recent round on record is Seed.

Public record

SEC filings, insider activity, nonprofit links and pay benchmarks for Laverock Therapeutics